Fulton Bank, N.A. Jazz Pharmaceuticals PLC Transaction History

Fulton Bank, N.A.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 03, 2020	SELL	$87.74 - $152.74 $198,204 - $345,039	-2,259 Closed	0 $0
Q4 2019 Jan 24, 2020	SELL	$117.65 - $153.73 $4,706 - $6,149	-40 Reduced 1.74%	2,259 $337,000
Q3 2019 Oct 03, 2019	BUY	$125.18 - $143.24 $27,539 - $31,512	220 Added 10.58%	2,299 $295,000
Q2 2019 Jul 03, 2019	SELL	$125.55 - $144.48 $6,905 - $7,946	-55 Reduced 2.58%	2,079 $297,000
Q1 2019 Apr 03, 2019	SELL	$121.81 - $142.95 $116,815 - $137,089	-959 Reduced 31.01%	2,134 $305,000
Q4 2018 Jan 03, 2019	SELL	$115.94 - $166.74 $41,042 - $59,025	-354 Reduced 10.27%	3,093 $383,000
Q3 2018 Oct 03, 2018	BUY	$161.01 - $180.57 $483 - $541	3 Added 0.09%	3,447 $580,000
Q2 2018 Jul 10, 2018	BUY	$146.33 - $183.18 $72,726 - $91,040	497 Added 16.86%	3,444 $593,000
Q1 2018 May 02, 2018	BUY	$135.59 - $157.16 $6,101 - $7,072	45 Added 1.55%	2,947 $445,000
Q4 2017 Jan 04, 2018	SELL	$131.06 - $150.39 $29,750 - $34,138	-227 Reduced 7.25%	2,902 $391,000
Q3 2017 Oct 04, 2017	BUY	$142.62 - $155.6 $446,257 - $486,872	3,129	3,129 $457,000

513

57.7M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.62B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Fulton Bank, N.A., based on Form 13F filings with the SEC.

Stay updated on Fulton Bank, N.A. with notifications on news.